Literature DB >> 15955146

Outcomes and health-related quality of life following hospitalization for an acute exacerbation of COPD.

Qiuyue Wang1, Jean Bourbeau.   

Abstract

OBJECTIVE: The purpose of this study was to understand the outcomes for patients admitted to hospital for an acute exacerbation of COPD, and to determine the factors influencing quality of life and health service utilization of patients with COPD.
METHODOLOGY: Hospital outcomes of 282 patients with moderate and severe COPD, for an acute exacerbation, were retrospectively evaluated. After 24 months of follow up, health-related quality of life (QoL) and health service utilization (emergency room (ER) visit and readmission) in 54 patients admitted previously, were surveyed by questionnaires.
RESULTS: Of 282 COPD patients admitted for an acute exacerbation, 28 patients (9.9%) died during hospitalization, 241 patients (85.5%) were discharged home, and only 13 patients (4.6%) needed long-term care facilities. Although over 50% of the patients had survived over 2 years after discharge, their QoL was poor. Patients who frequently went to the ER or were admitted, were those with poor QoL, severe dyspnoea and frequent exacerbation. COPD exacerbation and dyspnoea were the main factors influencing QoL of the patients. Age, comorbidity, QoL, FEV1, frequency of COPD exacerbation, long-term oxygen therapy, and family doctor were the factors determining the likelihood of patients visiting the ER. Frequency of COPD exacerbation, family doctor and living alone were the factors determining which patients were likely to be admitted to hospital.
CONCLUSION: The outcomes and QoL of patients admitted for an acute exacerbation of COPD were poor. The major factors influencing QoL were frequency of COPD exacerbation and severity of dyspnoea. Improvement of social and medical networks (e.g. reducing the number of patients living alone and providing family doctors for patients) may reduce health care service utilization.

Entities:  

Mesh:

Year:  2005        PMID: 15955146     DOI: 10.1111/j.1440-1843.2005.00718.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  34 in total

Review 1.  Systematic review of humanistic and economic burden of symptomatic chronic obstructive pulmonary disease.

Authors:  Kunal Srivastava; Deepika Thakur; Sheetal Sharma; Yogesh Suresh Punekar
Journal:  Pharmacoeconomics       Date:  2015-05       Impact factor: 4.981

2.  A Cross-sectional Study of Hospital Performance on ICU Utilization Practices for Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Kusum S Mathews; Neha N Goel; Carmen Vargas-Torres; Ashley D Olson; Jing Zhou; Charles A Powell; Madhu Mazumdar; Gregory N Stock; Christopher M McDermott
Journal:  Lung       Date:  2020-06-03       Impact factor: 2.584

3.  Recruiting Patients After Hospital Discharge for Acute Exacerbation of COPD: Challenges and Lessons Learned.

Authors:  Gary T Ferguson; Bonnie Beck; Emmanuelle Clerisme-Beaty; Dacheng Liu; Byron M Thomashow; Robert A Wise; Richard ZuWallack; Barry J Make
Journal:  Chronic Obstr Pulm Dis       Date:  2017-08-10

Review 4.  [Assessment, triage, and follow-up of a patient with: acute CAP COPD].

Authors:  K Faure
Journal:  Med Mal Infect       Date:  2006-11-07       Impact factor: 2.152

Review 5.  Pharmacogenetics of chronic obstructive pulmonary disease: challenges and opportunities.

Authors:  Craig P Hersh
Journal:  Pharmacogenomics       Date:  2010-02       Impact factor: 2.533

6.  Effectiveness and cost-effectiveness of early assisted discharge for chronic obstructive pulmonary disease exacerbations: the design of a randomised controlled trial.

Authors:  Cecile M A Utens; Lucas M A Goossens; Frank W J M Smeenk; Onno C P van Schayck; Walter van Litsenburg; Annet Janssen; Monique van Vliet; Wiel Seezink; Dirk R A J Demunck; Brigitte van de Pas; Peter J de Bruijn; Anouschka van der Pouw; Jeroen M A M Retera; Petra de Laat-Bierings; Loes van Eijsden; Maria Braken; Riet Eijsermans; Maureen P M H Rutten-van Mölken
Journal:  BMC Public Health       Date:  2010-10-18       Impact factor: 3.295

7.  Risk factors and outcomes associated with chronic obstructive pulmonary disease exacerbations requiring hospitalization.

Authors:  Katayoun Bahadori; J Mark FitzGerald; Robert D Levy; Tharwat Fera; John Swiston
Journal:  Can Respir J       Date:  2009 Jul-Aug       Impact factor: 2.409

8.  Factors associated with short-term recovery of health status among emergency department patients with acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Chu-Lin Tsai; Brian H Rowe; Carlos A Camargo
Journal:  Qual Life Res       Date:  2009-01-04       Impact factor: 4.147

9.  Exacerbations, Health Resource Utilization, and Costs Among Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease Treated with Nebulized Arformoterol Following a Respiratory Event.

Authors:  Maryam Navaie; Bartolome R Celli; Zhun Xu; Soojin Cho-Reyes; Carole Dembek; Todd P Gilmer
Journal:  Chronic Obstr Pulm Dis       Date:  2019-10-23

Review 10.  Inhaled corticosteroids with combination inhaled long-acting beta2-agonists and long-acting muscarinic antagonists for chronic obstructive pulmonary disease.

Authors:  Daniel J Tan; Clinton J White; Julia Ae Walters; E Haydn Walters
Journal:  Cochrane Database Syst Rev       Date:  2016-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.